Welcome to CDC stacks | Stopping the Control Arm in Response to the DSMB: Mother’s Choice of HIV Prophylaxis during Breastfeeding in the BAN Study - 33292 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Stopping the Control Arm in Response to the DSMB: Mother’s Choice of HIV Prophylaxis during Breastfeeding in the BAN Study
Filetype[PDF-297.45 KB]


Details:
No Related Documents.
You May Also Like:
  1. Delayed HIV detection among infants exposed to postnatal antiretroviral prophylaxis during breastfeeding
    Personal Author:
    King, Caroline C.; Kourtis, Athena P.; Persaud, Deborah; Nelson, Julie A.E.; Ziemniak, Carrie; Hudgens, Michael G.; Tegha, Gerald; Chasela, Charles S.; Jamieson, Denise J.; van der Horst, Charles M.;
    Published:
    Sep 24 2015
    Source:
    AIDS. 29(15):1953-1961.
    Description:
    Objective : The objective of this study is to determine whether detection of HIV infection was delayed in infants exposed to antiretroviral prophylaxis to prevent HIV transmission during breastfeeding. : Design : The Breastfeeding, Antiretrovirals an...
    File Type:
    Filetype[PDF - 608.86 KB]
  2. Antiretroviral treatment is associated with iron deficiency in HIV-infected Malawian women that is mitigated with supplementation, but is not associated with infant iron deficiency during 24 weeks of exclusive breastfeeding
    Personal Author:
    Widen, Elizabeth M.; Bentley, Margaret E.; Chasela, Charles S.; Kayira, Dumbani; Flax, Valerie L.; Kourtis, Athena P.; Ellington, Sascha R.; Kacheche, Zebrone; Tegha, Gerald; Jamieson, Denise J.; van der Horst, Charles M.; Allen, Lindsay H.; Shahab-Ferdows, Setareh; Adair, Linda S.;
    Published:
    Jul 1 2015
    Source:
    J Acquir Immune Defic Syndr. 69(3):319-328.
    Description:
    Objective : In resource-limited settings without safe alternatives to breastfeeding, the WHO recommends exclusive breastfeeding and antiretroviral (ARV) prophylaxis. Given the high prevalence of anemia among HIV-infected women, mothers and their infa...
    File Type:
    Filetype[PDF - 396.53 KB]
  3. Health outcomes of HIV-exposed uninfected African infants
    Personal Author:
    Kourtis, Athena P.; Wiener, Jeffrey; Kayira, Dumbani; Chasela, Charles; Ellington, Sascha R.; Hyde, Lisa; Hosseinipour, Mina; van der Horst, Charles; Jamieson, Denise J.;
    Published:
    Mar 13 2013
    Source:
    AIDS. 2013; 27(5):749-759.
    Description:
    Objectives : To evaluate severe (grade 3/4) morbidity and mortality in HIV-exposed, uninfected infants. : Design : Secondary data analysis of The Breastfeeding, Antiretrovirals, and Nutrition (BAN) clinical trial. : Methods : BAN randomized 2369 moth...
    File Type:
    Filetype[PDF - 420.04 KB]
  4. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial
    Personal Author:
    Jamieson, Denise J.; Chasela, Charles S.; Hudgens, Michael G.; King, Caroline C.; Kourtis, Athena P.; Kayira, Dumbani; Hosseinipour, Mina C.; Kamwendo, Deborah D.; Ellington, Sascha R.; Wiener, Jeffrey B.; Fiscus, Susan A.; Tegha, Gerald; Mofolo, Innocent A.; Sichali, Dorothy S.; Adair, Linda S.; Knight, Rodney J.; Martinson, Francis; Kacheche, Zebrone; Soko, Alice; Hoffman, Irving; van der Horst, Charles;
    Corporate Author:
    The BAN study team
    Published:
    Apr 26 2012
    Source:
    Lancet. 379(9835):2449-2458.
    Description:
    Background : In resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to either HIV-infected mothers or infants throughout breastfeeding. We assessed the effect of 28 week...
    File Type:
    Filetype[PDF - 646.80 KB]
  5. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States
    Corporate Author:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.
    Published:
    September 14, 2011
    Status:
    current
    File Type:
    Filetype[PDF - 155.10 MB]